Truehand Inc’s Gilead Sciences GILD Stock Holding History

Truehand Inc’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$19K	Hold	266	–	–	0.01%	153
2021 Q3	$19K	Hold	266	–	–	0.01%	155
2021 Q2	$18K	Hold	266	–	–	0.01%	155
2021 Q1	$17K	Hold	266	–	–	0.01%	157
2020 Q4	$15K	Hold	266	–	–	0.01%	163
2020 Q3	$17K	Hold	266	–	–	0.01%	157
2020 Q2	$20K	Hold	266	–	–	0.02%	153
2020 Q1	$20K	Hold	266	–	–	0.02%	126
2019 Q4	$17K	Hold	266	–	–	0.01%	134
2019 Q3	$17K	Hold	266	–	–	0.01%	134
2019 Q2	$18K	Hold	266	–	–	0.01%	136
2019 Q1	$17K	Hold	266	–	–	0.01%	143
2018 Q4	$17K	Buy	+266	New	+$18.6K	0.01%	142

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Truehand Inc's GILD Position: Q4 2021 in Review

Truehand Inc held its Gilead Sciences (GILD) position steady in Q4 2021 at 266 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #153.

Truehand Inc first reported a position in GILD in Q4 2018 and has held it in 13 quarters since. The position peaked at $20K in Q2 2020. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

Truehand Inc held 266 shares of Gilead Sciences worth $19K as of Q4 2021.
Truehand Inc left its Gilead Sciences share count unchanged in Q4 2021.
Gilead Sciences made up 0.01% of Truehand Inc's portfolio in Q4 2021, its #153 holding.
Truehand Inc first reported a position in Gilead Sciences in Q4 2018 and has held it in 13 quarters since.
Truehand Inc's Gilead Sciences position peaked at $20K in Q2 2020.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Truehand Inc's 13F filing for Q4 2021, filed 9 Feb 2022.